Big update
4 Aug 2026
Second quarter 2026 financial results announced
Shows how much money the company made and spent in the last three months.
SEC 10-Q · filed 2026-08-04
View filing ↗
What's happening at Pacira BioSciences, Inc.
Pacira BioSciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026
Deal
4 Aug 2026
Sells CryoTech cryoanalgesia unit to Zimmer Biomet for $140 million
Company receives cash upfront and future payments if iovera sales reach certain targets through 2031.
SEC 8-K · filed 2026-08-04
View filing ↗
Governance
30 Jun 2026
Stockholders approve 800,000 new shares for employee stock purchase plan
Lets employees buy company stock; more shares available means existing owners' stakes get slightly diluted.
SEC 8-K · filed 2026-06-30
View filing ↗
Earnings
11 Jun 2026
First quarter 2026 financial results announced
Shows how much money the company made and spent in the first three months of the year.
SEC 8-K · filed 2026-06-11
View filing ↗
Earnings
30 Apr 2026
Full year 2025 results filed with SEC
Annual report shows total money earned, spent, and owned for the entire previous year.
SEC 10-Q · filed 2026-04-30
View filing ↗
Common questions
How does Stocky track Pacira BioSciences, Inc.'s company events?
Stocky reads Pacira BioSciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
What was Pacira BioSciences, Inc.'s most recent SEC filing?
Pacira BioSciences, Inc.'s most recent tracked filing was a 10-Q on 4 Aug 2026: Second quarter 2026 financial results announced.
Is this financial advice?
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.